Platinum-Refractory Ovarian Carcinoma
generalOvarian carcinoma that progresses during platinum therapy or within one month of completing platinum therapy.
39
Centers
41
Active Trials
—
Cancer Funding
Specific Cancer Types(1)
Top Centers for Platinum-Refractory Ovarian Carcinoma(39)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive High-Volume Research Center | 72.1 |
| 2 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive High-Volume Research Center | 72.1 |
| 3 | Georgia Cancer Center, Augusta UniversityAugusta, GA High-Volume Research Center | 72.1 |
| 4 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 50.1 |
| 5 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 50.1 |
| 6 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 50.1 |
| 7 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 50.1 |
| 8 | NCI Comprehensive Active Research Program | 50.1 |
| 9 | NCI Comprehensive Active Research Program | 50.1 |
| 10 | NCI Comprehensive Active Research Program | 50.1 |
| 11 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 50.1 |
| 12 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 50.1 |
| 13 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 50.1 |
| 14 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 50.1 |
| 15 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 50.1 |
| 16 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 50.1 |
| 17 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 50.1 |
| 18 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 50.1 |
| 19 | NCI Clinical Active Research Program | 50.1 |
| 20 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 50.1 |
| 21 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 50.1 |
| 22 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 50.1 |
| 23 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 50.1 |
| 24 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 50.1 |
| 25 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 50.1 |
| 26 | University of Illinois Cancer CenterChicago, IL Active Research Program | 50.1 |
| 27 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 50.1 |
| 28 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 50.1 |
| 29 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 50.1 |
| 30 | Boston University Cancer CenterBoston, MA Active Research Program | 50.1 |
| 31 | Active Research Program | 50.1 |
| 32 | Cancer Center at IllinoisUrbana, IL Active Research Program | 50.1 |
| 33 | Penn State Cancer InstituteHershey, PA Active Research Program | 50.1 |
| 34 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 50.1 |
| 35 | Active Research Program | 50.1 |
| 36 | Northwell Health Cancer InstituteNew York, NY Active Research Program | 50.1 |
| 37 | Upstate Cancer CenterSyracuse, NY Active Research Program | 50.1 |
| 38 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 50.1 |
| 39 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive | 29.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →